Status:
COMPLETED
Concomitant Chemoradiation in Advanced Stage Carcinoma Cervix
Lead Sponsor:
Tata Memorial Hospital
Conditions:
Cancer of Cervix
Eligibility:
FEMALE
18-65 years
Phase:
NA
Brief Summary
A study to evaluate the efficacy of concomitant chemoradiation as compared to radiotherapy alone. Concomitant chemoradiation is not a new treatment modality for carcinoma cervix. Studies have shown im...
Detailed Description
Carcinoma cervix is the commonest malignancy seen in Asian women and constitutes approximately 30% of all cancers (1). It is also the leading cause of cancer mortality in India. Nearly 50% of the pati...
Eligibility Criteria
Inclusion
- Histologically proven squamous carcinoma of cervix
- Performance index world health organization (WHO) grade 0 or 1
- Patients below 65 years of age
- FIGO Stage IIIB
- Normal ECG and Cardiovascular system
- Normal hematological parameters
- Normal renal and liver function tests
Exclusion
- Co-morbid conditions like medical renal disease
- Medical or Psychological condition that would preclude treatment
- H/o Previous treatment / Pregnancy
- Patient unreliable for treatment completion and follow-up.
Key Trial Info
Start Date :
July 7 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2017
Estimated Enrollment :
850 Patients enrolled
Trial Details
Trial ID
NCT00193791
Start Date
July 7 2003
End Date
December 1 2017
Last Update
September 17 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tata Memorial Hospital
Mumbai, Maharashtra, India, 400 012